annual current liabilities:
$80.91M-$18.96M(-18.98%)Summary
- As of today (September 15, 2025), AKBA annual total current liabilities is $80.91 million, with the most recent change of -$18.96 million (-18.98%) on December 31, 2024.
- During the last 3 years, AKBA annual current liabilities has fallen by -$180.14 million (-69.00%).
- AKBA annual current liabilities is now -69.55% below its all-time high of $265.69 million, reached on December 31, 2018.
Performance
AKBA Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$118.72M+$27.49M(+30.13%)Summary
- As of today (September 15, 2025), AKBA quarterly total current liabilities is $118.72 million, with the most recent change of +$27.49 million (+30.13%) on June 1, 2025.
- Over the past year, AKBA quarterly current liabilities has increased by +$11.42 million (+10.64%).
- AKBA quarterly current liabilities is now -55.32% below its all-time high of $265.69 million, reached on December 31, 2018.
Performance
AKBA quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
AKBA Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.0% | +10.6% |
| 3 y3 years | -69.0% | -49.2% |
| 5 y5 years | -61.1% | -39.4% |
AKBA Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -69.0% | at low | -49.2% | +80.7% |
| 5 y | 5-year | -69.0% | at low | -54.5% | +80.7% |
| alltime | all time | -69.5% | +4352.7% | -55.3% | +2942.6% |
AKBA Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $118.72M(+30.1%) |
| Mar 2025 | - | $91.23M(+12.7%) |
| Dec 2024 | $80.91M(-19.0%) | $80.91M(+23.1%) |
| Sep 2024 | - | $65.71M(-38.8%) |
| Jun 2024 | - | $107.30M(+61.4%) |
| Mar 2024 | - | $66.49M(-33.4%) |
| Dec 2023 | $99.87M(-22.9%) | $99.87M(+25.3%) |
| Sep 2023 | - | $79.70M(-13.5%) |
| Jun 2023 | - | $92.18M(+11.1%) |
| Mar 2023 | - | $82.94M(-36.0%) |
| Dec 2022 | $129.54M(-50.4%) | $129.54M(-31.1%) |
| Sep 2022 | - | $187.97M(-19.6%) |
| Jun 2022 | - | $233.68M(-8.0%) |
| Mar 2022 | - | $253.91M(-2.7%) |
| Dec 2021 | $261.05M(+39.5%) | $261.05M(+38.0%) |
| Sep 2021 | - | $189.21M(+14.3%) |
| Jun 2021 | - | $165.59M(-4.1%) |
| Mar 2021 | - | $172.68M(-7.7%) |
| Dec 2020 | $187.15M(-10.1%) | $187.15M(+3.1%) |
| Sep 2020 | - | $181.46M(-7.3%) |
| Jun 2020 | - | $195.77M(-8.6%) |
| Mar 2020 | - | $214.15M(+2.9%) |
| Dec 2019 | $208.12M | $208.12M(-6.7%) |
| Sep 2019 | - | $223.15M(+20.2%) |
| Jun 2019 | - | $185.62M(-8.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $202.61M(-23.7%) |
| Dec 2018 | $265.69M(+88.3%) | $265.69M(+49.8%) |
| Sep 2018 | - | $177.40M(+7.9%) |
| Jun 2018 | - | $164.42M(+8.6%) |
| Mar 2018 | - | $151.42M(+7.3%) |
| Dec 2017 | $141.11M(+23.5%) | $141.11M(-6.8%) |
| Sep 2017 | - | $151.36M(-16.6%) |
| Jun 2017 | - | $181.59M(+36.1%) |
| Mar 2017 | - | $133.46M(+16.8%) |
| Dec 2016 | $114.27M(+862.8%) | $114.27M(+337.2%) |
| Sep 2016 | - | $26.14M(+24.9%) |
| Jun 2016 | - | $20.93M(+56.1%) |
| Mar 2016 | - | $13.41M(+13.0%) |
| Dec 2015 | $11.87M(+72.4%) | $11.87M(-16.2%) |
| Sep 2015 | - | $14.17M(+140.0%) |
| Jun 2015 | - | $5.90M(-33.2%) |
| Mar 2015 | - | $8.84M(+28.4%) |
| Dec 2014 | $6.88M(+76.5%) | $6.88M(+5.6%) |
| Sep 2014 | - | $6.52M(+36.7%) |
| Jun 2014 | - | $4.77M(-22.1%) |
| Mar 2014 | - | $6.12M(+56.9%) |
| Dec 2013 | $3.90M(-20.7%) | $3.90M(-20.7%) |
| Dec 2012 | $4.92M(+170.9%) | - |
| Dec 2012 | - | $4.92M |
| Dec 2011 | $1.82M | - |
FAQ
- What is Akebia Therapeutics, Inc. annual total current liabilities?
- What is the all time high annual current liabilities for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. annual current liabilities year-on-year change?
- What is Akebia Therapeutics, Inc. quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. quarterly current liabilities year-on-year change?
What is Akebia Therapeutics, Inc. annual total current liabilities?
The current annual current liabilities of AKBA is $80.91M
What is the all time high annual current liabilities for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high annual total current liabilities is $265.69M
What is Akebia Therapeutics, Inc. annual current liabilities year-on-year change?
Over the past year, AKBA annual total current liabilities has changed by -$18.96M (-18.98%)
What is Akebia Therapeutics, Inc. quarterly total current liabilities?
The current quarterly current liabilities of AKBA is $118.72M
What is the all time high quarterly current liabilities for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high quarterly total current liabilities is $265.69M
What is Akebia Therapeutics, Inc. quarterly current liabilities year-on-year change?
Over the past year, AKBA quarterly total current liabilities has changed by +$11.42M (+10.64%)